Global Hemoglobinopathy Drugs Industry Research Report 2020, Forecast to 2025

August 2020 | 104 pages | ID: G6B9DA00DD73EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Hemoglobinopathy Drugs market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Hemoglobinopathy Drugs is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Hemoglobinopathy Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hemoglobinopathy Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Hemoglobinopathy Drugs market are discussed.

The market is segmented by types:

• Hydroxyurea
• Glutamine
• Zynteglo
• Other

It can be also divided by applications:

• Sickle Cell Diseases
• Thalassemia

And this report covers the historical situation, present status and the future prospects of the global Hemoglobinopathy Drugs market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Novartis
• Eli Lilly and Company
• Bristol-Myers Squibb
• AstraZeneca
• HemaQuest Pharmaceuticals
• Bluebird
• Acceleron Pharma
• Emmaus Medical
• Celgene

Report Includes:

• xx data tables and xx additional tables
• An overview of global Hemoglobinopathy Drugs market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Hemoglobinopathy Drugs market
• Profiles of major players in the industry, including Novartis, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca, HemaQuest Pharmaceuticals.....

Research Objectives

• To study and analyze the global Hemoglobinopathy Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Hemoglobinopathy Drugs market by identifying its various subsegments.
• Focuses on the key global Hemoglobinopathy Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Hemoglobinopathy Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Hemoglobinopathy Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Hemoglobinopathy Drugs Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Hemoglobinopathy Drugs Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 HEMOGLOBINOPATHY DRUGS INDUSTRY OVERVIEW

2.1 Global Hemoglobinopathy Drugs Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Hemoglobinopathy Drugs Global Import Market Analysis
  2.1.2 Hemoglobinopathy Drugs Global Export Market Analysis
  2.1.3 Hemoglobinopathy Drugs Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Hydroxyurea
  2.2.2 Glutamine
  2.2.3 Zynteglo
  2.2.4 Other
2.3 Market Analysis by Application
  2.3.1 Sickle Cell Diseases
  2.3.2 Thalassemia
2.4 Global Hemoglobinopathy Drugs Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Hemoglobinopathy Drugs Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Hemoglobinopathy Drugs Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Hemoglobinopathy Drugs Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Hemoglobinopathy Drugs Manufacturer Market Share
  2.4.5 Top 10 Hemoglobinopathy Drugs Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Hemoglobinopathy Drugs Market
  2.4.7 Key Manufacturers Hemoglobinopathy Drugs Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Hemoglobinopathy Drugs Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Hemoglobinopathy Drugs Industry Impact
  2.7.1 How the Covid-19 is Affecting the Hemoglobinopathy Drugs Industry
  2.7.2 Hemoglobinopathy Drugs Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Hemoglobinopathy Drugs Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Hemoglobinopathy Drugs Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL HEMOGLOBINOPATHY DRUGS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Hemoglobinopathy Drugs Sales Market Share by Region
4.2 Global Hemoglobinopathy Drugs Revenue Market Share by Region (2015-2019)
4.3 Global Hemoglobinopathy Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Hemoglobinopathy Drugs Market Size Detail
  4.4.1 North America Hemoglobinopathy Drugs Sales Growth Rate (2015-2020)
  4.4.2 North America Hemoglobinopathy Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Hemoglobinopathy Drugs Market Size Detail
  4.5.1 Europe Hemoglobinopathy Drugs Sales Growth Rate (2015-2020)
  4.5.2 Europe Hemoglobinopathy Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Hemoglobinopathy Drugs Market Size Detail
  4.6.1 Japan Hemoglobinopathy Drugs Sales Growth Rate (2015-2020)
  4.6.2 Japan Hemoglobinopathy Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Hemoglobinopathy Drugs Market Size Detail
  4.7.1 China Hemoglobinopathy Drugs Sales Growth Rate (2015-2020)
  4.7.2 China Hemoglobinopathy Drugs Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL HEMOGLOBINOPATHY DRUGS MARKET SEGMENT BY TYPE

5.1 Global Hemoglobinopathy Drugs Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Hemoglobinopathy Drugs Sales and Market Share by Type (2015-2020)
  5.1.2 Global Hemoglobinopathy Drugs Revenue and Market Share by Type (2015-2020)
5.2 Hydroxyurea Sales Growth Rate and Price
  5.2.1 Global Hydroxyurea Sales Growth Rate (2015-2020)
  5.2.2 Global Hydroxyurea Price (2015-2020)
5.3 Glutamine Sales Growth Rate and Price
  5.3.1 Global Glutamine Sales Growth Rate (2015-2020)
  5.3.2 Global Glutamine Price (2015-2020)
5.4 Zynteglo Sales Growth Rate and Price
  5.4.1 Global Zynteglo Sales Growth Rate (2015-2020)
  5.4.2 Global Zynteglo Price (2015-2020)
5.5 Other Sales Growth Rate and Price
  5.5.1 Global Other Sales Growth Rate (2015-2020)
  5.5.2 Global Other Price (2015-2020)

6 GLOBAL HEMOGLOBINOPATHY DRUGS MARKET SEGMENT BY APPLICATION

6.1 Global Hemoglobinopathy DrugsSales Market Share by Application (2015-2020)
6.2 Sickle Cell Diseases Sales Growth Rate (2015-2020)
6.3 Thalassemia Sales Growth Rate (2015-2020)

7 GLOBAL HEMOGLOBINOPATHY DRUGS MARKET FORECAST

7.1 Global Hemoglobinopathy Drugs Sales, Revenue Forecast
  7.1.1 Global Hemoglobinopathy Drugs Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Hemoglobinopathy Drugs Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Hemoglobinopathy Drugs Price and Trend Forecast (2020-2025)
7.2 Global Hemoglobinopathy Drugs Sales Forecast by Region (2020-2025)
  7.2.1 North America Hemoglobinopathy Drugs Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Hemoglobinopathy Drugs Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Hemoglobinopathy Drugs Production, Revenue Forecast (2020-2025)
  7.2.4 China Hemoglobinopathy Drugs Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF HEMOGLOBINOPATHY DRUGS INDUSTRY KEY MANUFACTURERS

8.1 Novartis
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Novartis Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Novartis News
8.2 Eli Lilly and Company
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Eli Lilly and Company Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Eli Lilly and Company News
8.3 Bristol-Myers Squibb
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Bristol-Myers Squibb Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Bristol-Myers Squibb News
8.4 AstraZeneca
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 AstraZeneca Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 AstraZeneca News
8.5 HemaQuest Pharmaceuticals
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 HemaQuest Pharmaceuticals News
8.6 Bluebird
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Bluebird Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Bluebird News
8.7 Acceleron Pharma
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Acceleron Pharma Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Acceleron Pharma News
8.8 Emmaus Medical
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Emmaus Medical Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Emmaus Medical News
8.9 Celgene
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Celgene Hemoglobinopathy Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Celgene News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hemoglobinopathy Drugs Picture
Figure Research Programs/Design for This Report
Figure Global Hemoglobinopathy Drugs Market by Regions (2019)
Table Global Market Hemoglobinopathy Drugs Comparison by Regions (M USD) 2019-2025
Table Global Hemoglobinopathy Drugs Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Hemoglobinopathy Drugs by Type in 2019
Figure Hydroxyurea Picture
Figure Glutamine Picture
Figure Zynteglo Picture
Figure Other Picture
Table Global Hemoglobinopathy Drugs Sales by Application (2019-2025)
Figure Global Hemoglobinopathy Drugs Sales Market Share by Application in 2019
Figure Sickle Cell Diseases Picture
Figure Thalassemia Picture
Table Global Hemoglobinopathy Drugs Sales by Manufacturer (2018-2020)
Figure Global Hemoglobinopathy Drugs Sales Market Share by Manufacturer in 2019
Table Global Hemoglobinopathy Drugs Revenue by Manufacturer (2018-2020)
Figure Global Hemoglobinopathy Drugs Revenue Market Share by Manufacturer in 2019
Table Global Hemoglobinopathy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Hemoglobinopathy Drugs Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Hemoglobinopathy Drugs Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Hemoglobinopathy Drugs Market
Table Key Manufacturers Hemoglobinopathy Drugs Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemoglobinopathy Drugs
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Hemoglobinopathy Drugs Sales (K Units) by Region (2015-2020)
Table Global Hemoglobinopathy Drugs Sales Market Share by Region (2015-2019)
Figure Global Hemoglobinopathy Drugs Sales Market Share by Region (2015-2019)
Figure Global Hemoglobinopathy Drugs Sales Market Share by Region in 2018
Table Global Hemoglobinopathy Drugs Revenue (Million US$) by Region (2015-2020)
Table Global Hemoglobinopathy Drugs Revenue Market Share by Region (2015-2020)
Figure Global Hemoglobinopathy Drugs Revenue Market Share by Region (2015-2020)
Figure Global Hemoglobinopathy Drugs Revenue Market Share by Region in 2019
Table Global Hemoglobinopathy Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Hemoglobinopathy Drugs Sales (K Units) Growth Rate (2015-2020)
Table North America Hemoglobinopathy Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Hemoglobinopathy Drugs Sales (K Units) Growth Rate (2015-2020)
Table Europe Hemoglobinopathy Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Hemoglobinopathy Drugs Sales (K Units) Growth Rate (2015-2020)
Table Japan Hemoglobinopathy Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Hemoglobinopathy Drugs Sales (K Units) Growth Rate (2015-2020)
Table China Hemoglobinopathy Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Hemoglobinopathy Drugs Sales by Type (2015-2020)
Table Global Hemoglobinopathy Drugs Sales Market Share by Type (2015-2020)
Figure Global Hemoglobinopathy Drugs Sales Market Share by Type in 2019
Table Global Hemoglobinopathy Drugs Revenue by Type (2015-2020)
Table Global Hemoglobinopathy Drugs Revenue Market Share by Type (2015-2020)
Figure Global Hemoglobinopathy Drugs Revenue Market Share by Type in 2019
Figure Global Hydroxyurea Sales Growth Rate (2015-2020)
Figure Global Hydroxyurea Price (2015-2020)
Figure Global Glutamine Sales Growth Rate (2015-2020)
Figure Global Glutamine Price (2015-2020)
Figure Global Zynteglo Sales Growth Rate (2015-2020)
Figure Global Zynteglo Price (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global Hemoglobinopathy Drugs Sales by Application (2015-2020)
Table Global Hemoglobinopathy Drugs Sales Market Share by Application (2015-2020)
Figure Global Hemoglobinopathy Drugs Sales Market Share by Application in 2019
Figure Global Sickle Cell Diseases Sales Growth Rate (2015-2020)
Figure Global Thalassemia Sales Growth Rate (2015-2020)
Figure Global Hemoglobinopathy Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Hemoglobinopathy Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Hemoglobinopathy Drugs Price and Trend Forecast (2020-2025)
Table Global Hemoglobinopathy Drugs Sales (K Units) Forecast by Region (2020-2025)
Figure Global Hemoglobinopathy Drugs Production Market Share Forecast by Region (2020-2025)
Figure North America Hemoglobinopathy Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Hemoglobinopathy Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Hemoglobinopathy Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Hemoglobinopathy Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Hemoglobinopathy Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Hemoglobinopathy Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Hemoglobinopathy Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Hemoglobinopathy Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Novartis Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of Novartis
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis Hemoglobinopathy Drugs Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Eli Lilly and Company Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of Eli Lilly and Company
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lilly and Company Hemoglobinopathy Drugs Market Share (2018-2020)
Table Eli Lilly and Company Main Business
Table Eli Lilly and Company Recent Development
Table Bristol-Myers Squibb Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of Bristol-Myers Squibb
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bristol-Myers Squibb Hemoglobinopathy Drugs Market Share (2018-2020)
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table AstraZeneca Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of AstraZeneca
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Hemoglobinopathy Drugs Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table HemaQuest Pharmaceuticals Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of HemaQuest Pharmaceuticals
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Market Share (2018-2020)
Table HemaQuest Pharmaceuticals Main Business
Table HemaQuest Pharmaceuticals Recent Development
Table Bluebird Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of Bluebird
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bluebird Hemoglobinopathy Drugs Market Share (2018-2020)
Table Bluebird Main Business
Table Bluebird Recent Development
Table Acceleron Pharma Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of Acceleron Pharma
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Acceleron Pharma Hemoglobinopathy Drugs Market Share (2018-2020)
Table Acceleron Pharma Main Business
Table Acceleron Pharma Recent Development
Table Emmaus Medical Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of Emmaus Medical
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Emmaus Medical Hemoglobinopathy Drugs Market Share (2018-2020)
Table Emmaus Medical Main Business
Table Emmaus Medical Recent Development
Table Celgene Company Profile
Figure Hemoglobinopathy Drugs Product Picture and Specifications of Celgene
Table Hemoglobinopathy Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Celgene Hemoglobinopathy Drugs Market Share (2018-2020)
Table Celgene Main Business
Table Celgene Recent Development
Table of Appendix